Found: 80
Select item for more details and to access through your institution.
Comparison of clinical features between patients with anti-synthetase syndrome and dermatomyositis: results from the MYONET registry.
- Published in:
- Rheumatology, 2024, v. 63, n. 8, p. 2093, doi. 10.1093/rheumatology/kead481
- By:
- Publication type:
- Article
Collating the voice of people with autoimmune diseases: Methodology for the Third Phase of the COVAD Studies.
- Published in:
- Rheumatology International, 2024, v. 44, n. 7, p. 1233, doi. 10.1007/s00296-024-05562-z
- By:
- Publication type:
- Article
Clinical and prognostic associations of anti-Jo-1 antibody levels in patients with antisynthetase syndrome.
- Published in:
- Respiratory Research, 2024, v. 25, n. 1, p. 1, doi. 10.1186/s12931-024-02851-w
- By:
- Publication type:
- Article
Prognostic value of elevated lipoprotein (a) in patients with acute coronary syndromes: a systematic review and meta-analysis.
- Published in:
- Frontiers in Cardiovascular Medicine, 2024, p. 1, doi. 10.3389/fcvm.2024.1362893
- By:
- Publication type:
- Article
Prevalence, Risk Factors, and Mortality of Invasive Pulmonary Aspergillosis in Patients with Anti-MDA5+ Dermatomyositis: A Retrospective Study in China.
- Published in:
- Journal of Inflammation Research, 2024, v. 17, p. 3247, doi. 10.2147/JIR.S460702
- By:
- Publication type:
- Article
Fatty infiltration in the posterior muscles of the lower extremities as an MRI feature in antimitochondrial antibody–associated myopathy.
- Published in:
- Clinical Rheumatology, 2024, v. 43, n. 3, p. 1127, doi. 10.1007/s10067-024-06877-9
- By:
- Publication type:
- Article
COASY variant as a new genetic cause of riboflavin-responsive lipid storage myopathy.
- Published in:
- Cell Discovery, 2024, v. 10, n. 1, p. 1, doi. 10.1038/s41421-023-00641-0
- By:
- Publication type:
- Article
Chemical modification and blocking ratio assessment of Taq DNA polymerases using a 2,4,6-trinitrobenzenesulfonic acid (TNBS)-based assay.
- Published in:
- ScienceAsia, 2024, v. 50, n. 1, p. 1, doi. 10.2306/scienceasia1513-1874.2024.015
- By:
- Publication type:
- Article
Anti-Toxoplasma gondii antibodies as a risk factor for the prevalence and severity of systemic lupus erythematosus.
- Published in:
- Parasites & Vectors, 2024, v. 17, n. 1, p. 1, doi. 10.1186/s13071-024-06141-8
- By:
- Publication type:
- Article
High prevalence and mortality of Pneumocystis jirovecii pneumonia in anti-MDA5 antibody-positive dermatomyositis.
- Published in:
- Rheumatology, 2023, v. 62, n. 10, p. 3302, doi. 10.1093/rheumatology/kead063
- By:
- Publication type:
- Article
Clinical characteristics of myositis patients with isolated anti-U1 ribonucleoprotein antibody resemble immune-mediated necrotizing myopathy.
- Published in:
- Therapeutic Advances in Musculoskeletal Disease, 2023, p. 1, doi. 10.1177/1759720X231181336
- By:
- Publication type:
- Article
Long‐Term Outcomes and Prognosis Factors in Patients With Idiopathic Inflammatory Myopathies Based on Myositis‐Specific Autoantibodies: A Single Cohort Study.
- Published in:
- Arthritis Care & Research, 2023, v. 75, n. 5, p. 1175, doi. 10.1002/acr.24993
- By:
- Publication type:
- Article
Peripheral lymphocyte count defines the clinical phenotypes and prognosis in patients with anti‐MDA5‐positive dermatomyositis.
- Published in:
- Journal of Internal Medicine, 2023, v. 293, n. 4, p. 494, doi. 10.1111/joim.13607
- By:
- Publication type:
- Article
Clinical characteristics of myositis patients with isolated anti-U1 ribonucleoprotein antibody resemble immune-mediated necrotizing myopathy.
- Published in:
- Therapeutic Advances in Musculoskeletal Disease, 2023, v. 15, p. 1, doi. 10.1177/1759720X231181336
- By:
- Publication type:
- Article
The clinical features and prognoses of anti-MDA5 and anti-aminoacyl-tRNA synthetase antibody double-positive dermatomyositis patients.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.987841
- By:
- Publication type:
- Article
Thromboembolic events in idiopathic inflammatory myopathy: a retrospective study in China.
- Published in:
- Clinical Rheumatology, 2022, v. 41, n. 8, p. 2431, doi. 10.1007/s10067-022-06140-z
- By:
- Publication type:
- Article
Clinical Heterogeneity of Patients With Antinuclear Matrix Protein 2 Antibody-Positive Myositis: A Retrospective Cohort Study in China.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Adrenomedullin Expression Is Associated With the Severity and Poor Prognosis of Interstitial Lung Disease in Dermatomyositis Patients.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.885142
- By:
- Publication type:
- Article
Plasma exosomal RNAs have potential as both clinical biomarkers and therapeutic targets of dermatomyositis.
- Published in:
- Rheumatology, 2022, v. 61, n. 6, p. 2672, doi. 10.1093/rheumatology/keab753
- By:
- Publication type:
- Article
Clinical and pathological features of immune-mediated necrotising myopathies in a single-centre muscle biopsy cohort.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Interstitial Lung Disease in Dermatomyositis Without Myositis-Specific and Myositis-Associated Autoantibodies: Study of a Series of 72 Patients From a Single Cohort.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.879266
- By:
- Publication type:
- Article
Different Multivariable Risk Factors for Rapid Progressive Interstitial Lung Disease in Anti-MDA5 Positive Dermatomyositis and Anti-Synthetase Syndrome.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.845988
- By:
- Publication type:
- Article
Progranulin correlated with rapid progressive interstitial lung disease in dermatomyositis with anti-melanoma differentiation-associated gene 5 antibody.
- Published in:
- Clinical Rheumatology, 2022, v. 41, n. 3, p. 757, doi. 10.1007/s10067-021-05816-2
- By:
- Publication type:
- Article
Interstitial lung disease is not rare in immune-mediated necrotizing myopathy with anti-signal recognition particle antibodies.
- Published in:
- 2022
- By:
- Publication type:
- journal article
miR-18a-3p and Its Target Protein HuR May Regulate Myogenic Differentiation in Immune-Mediated Necrotizing Myopathy.
- Published in:
- Frontiers in Immunology, 2022, v. 12, p. 1, doi. 10.3389/fimmu.2021.780237
- By:
- Publication type:
- Article
Clinical role of bronchoalveolar lavage in dermatomyositis-associated interstitial lung disease.
- Published in:
- Rheumatology, 2022, v. 61, n. 1, p. 345, doi. 10.1093/rheumatology/keab586
- By:
- Publication type:
- Article
Spiral Motion Enhanced Elite Whale Optimizer for Global Tasks.
- Published in:
- Complexity, 2021, p. 1, doi. 10.1155/2021/8130378
- By:
- Publication type:
- Article
The effects of infliximab in treating idiopathic inflammatory myopathies: A review article.
- Published in:
- Dermatologic Therapy, 2021, v. 34, n. 4, p. 1, doi. 10.1111/dth.14976
- By:
- Publication type:
- Article
Anti-melanoma differentiation-associated gene 5 (MDA5) antibody-positive dermatomyositis responds to rituximab therapy.
- Published in:
- Clinical Rheumatology, 2021, v. 40, n. 6, p. 2311, doi. 10.1007/s10067-020-05530-5
- By:
- Publication type:
- Article
Clinical features, treatments and outcomes of calcinosis in adult patients with dermatomyositis: a single cohort study.
- Published in:
- Rheumatology, 2021, v. 60, n. 6, p. 2958, doi. 10.1093/rheumatology/keaa618
- By:
- Publication type:
- Article
Characterization of genotype-phenotype correlation with MORC2 mutated Axonal Charcot-Marie-Tooth disease in a cohort of Chinese patients.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Patient-reported outcomes from a randomized, double-blind, placebo controlled, phase III study of baricitinib versus placebo in patients with moderately to severely active rheumatoid arthritis and an inadequate response to methotrexate therapy: results from the RA-BALANCE study
- Published in:
- Therapeutic Advances in Musculoskeletal Disease, 2021, p. 1, doi. 10.1177/1759720X211006964
- By:
- Publication type:
- Article
The Efficacy of Tocilizumab in the Treatment of Patients with Refractory Immune-Mediated Necrotizing Myopathies: An Open-Label Pilot Study.
- Published in:
- Frontiers in Pharmacology, 2021, v. 11, p. N.PAG, doi. 10.3389/fphar.2021.635654
- By:
- Publication type:
- Article
Safety and Efficacy of Prefilled Liquid Etanercept-Biosimilar Yisaipu for Active Ankylosing Spondylitis: A Multi-Center Phase III Trial.
- Published in:
- Rheumatology & Therapy, 2021, v. 8, n. 1, p. 361, doi. 10.1007/s40744-021-00276-1
- By:
- Publication type:
- Article
Expansion of circulating peripheral TIGIT+CD226+ CD4 T cells with enhanced effector functions in dermatomyositis.
- Published in:
- Arthritis Research & Therapy, 2021, v. 23, n. 1, p. 1, doi. 10.1186/s13075-020-02397-4
- By:
- Publication type:
- Article
Patient-reported outcomes from a randomized, double-blind, placebo controlled, phase III study of baricitinib versus placebo in patients with moderately to severely active rheumatoid arthritis and an inadequate response to methotrexate therapy: results from the RA-BALANCE study
- Published in:
- Therapeutic Advances in Musculoskeletal Disease, 2021, p. 1, doi. 10.1177/1759720X211006964
- By:
- Publication type:
- Article
Interstitial lung disease is a major characteristic of anti-KS associated ant-synthetase syndrome.
- Published in:
- Therapeutic Advances in Chronic Disease, 2020, p. 1, doi. 10.1177/2040622320968417
- By:
- Publication type:
- Article
Clinical significance of radiological patterns of HRCT and their association with macrophage activation in dermatomyositis.
- Published in:
- Rheumatology, 2020, v. 59, n. 10, p. 2829, doi. 10.1093/rheumatology/keaa034
- By:
- Publication type:
- Article
Interstitial lung disease is a major characteristic of anti-KS associated ant-synthetase syndrome.
- Published in:
- Therapeutic Advances in Chronic Disease, 2020, p. 1, doi. 10.1177/2040622320968417
- By:
- Publication type:
- Article
Clinical features and outcomes of the patients with anti-glycyl tRNA synthetase syndrome.
- Published in:
- Clinical Rheumatology, 2020, v. 39, n. 8, p. 2417, doi. 10.1007/s10067-020-04979-8
- By:
- Publication type:
- Article
Soluble IL-2 Receptor in Dermatomyositis: Its Associations with Skin Ulcers and Disease Activity.
- Published in:
- Mediators of Inflammation, 2020, p. 1, doi. 10.1155/2020/6243019
- By:
- Publication type:
- Article
Pituitary dysfunction in patients with ANCA associated vasculitis: prevalence, presentation, and outcomes.
- Published in:
- Therapeutic Advances in Chronic Disease, 2020, v. 11, p. 1, doi. 10.1177/2040622320930636
- By:
- Publication type:
- Article
Pituitary dysfunction in patients with ANCA associated vasculitis: prevalence, presentation, and outcomes.
- Published in:
- Therapeutic Advances in Chronic Disease, 2020, p. 1, doi. 10.1177/2040622320930636
- By:
- Publication type:
- Article
Evaluation of 12 different assays for detecting ANCA in Chinese patients with GPA and MPA: a multicenter study in China.
- Published in:
- Clinical Rheumatology, 2019, v. 38, n. 12, p. 3477, doi. 10.1007/s10067-019-04736-6
- By:
- Publication type:
- Article
The spectrum and clinical significance of myositis-specific autoantibodies in Chinese patients with idiopathic inflammatory myopathies.
- Published in:
- Clinical Rheumatology, 2019, v. 38, n. 8, p. 2171, doi. 10.1007/s10067-019-04503-7
- By:
- Publication type:
- Article
Serum YKL-40 level is associated with severity of interstitial lung disease and poor prognosis in dermatomyositis with anti-MDA5 antibody.
- Published in:
- Clinical Rheumatology, 2019, v. 38, n. 6, p. 1655, doi. 10.1007/s10067-019-04457-w
- By:
- Publication type:
- Article
The RIG-I pathway is involved in peripheral T cell lymphopenia in patients with dermatomyositis.
- Published in:
- Arthritis Research & Therapy, 2019, v. 21, n. 1, p. N.PAG, doi. 10.1186/s13075-019-1905-z
- By:
- Publication type:
- Article
Serum-soluble TRAIL: a potential biomarker for disease activity in myositis patients.
- Published in:
- Clinical Rheumatology, 2019, v. 38, n. 5, p. 1425, doi. 10.1007/s10067-018-04418-9
- By:
- Publication type:
- Article
Maintenance of effect of duloxetine in Chinese patients with pain due to osteoarthritis: 13-week open-label extension data.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Efficacy and Safety of Loxoprofen Hydrogel Transdermal Patch Versus Loxoprofen Tablet in Chinese Patients with Myalgia: A Double-Blind, Double-Dummy, Parallel-Group, Randomized, Controlled, Non-Inferiority Trial.
- Published in:
- Clinical Drug Investigation, 2019, v. 39, n. 4, p. 369, doi. 10.1007/s40261-019-00756-x
- By:
- Publication type:
- Article